M05.06 Felty's syndrome, knee

Name of the Condition

• Felty's syndrome, knee

Summary

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the triad of rheumatoid arthritis, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). When affecting the knee, it involves chronic inflammation of the knee joint alongside systemic manifestations. The condition typically occurs in individuals with long-standing, severe rheumatoid arthritis and is associated with increased susceptibility to infections due to neutropenia.

Causes

Felty's syndrome is considered a variant of rheumatoid arthritis, though its exact cause is not fully understood. It is thought to result from chronic inflammation and immune dysregulation, leading to splenic sequestration of neutrophils and bone marrow suppression. The condition is strongly associated with high titers of rheumatoid factor and anti-citrullinated protein antibodies (ACPA). Knee involvement occurs as part of the broader rheumatoid arthritis process affecting multiple joints.

Risk Factors

• Long-standing, severe rheumatoid arthritis
• High titers of rheumatoid factor
• Presence of anti-citrullinated protein antibodies (ACPA)
• Advanced age (typically over 50 years)
• Female gender (more commonly affected)

Symptoms

• Persistent joint pain, swelling, and stiffness in the knee from underlying rheumatoid arthritis
• Fatigue and weakness
• Recurrent infections due to neutropenia
• Abdominal discomfort or fullness from splenomegaly
• Unexplained weight loss
• Skin discoloration or ulcers (less common)

Diagnosis

Diagnosis of Felty's syndrome, knee, requires confirmation of the triad of rheumatoid arthritis, splenomegaly, and neutropenia, with knee involvement documented. Clinical evaluation includes a thorough history of rheumatoid arthritis, physical examination of the knee and spleen, and laboratory tests to assess neutrophil counts, rheumatoid factor, and anti-citrullinated protein antibodies. Imaging of the knee may be performed to evaluate joint damage, while splenomegaly is typically confirmed via imaging or physical examination.

Treatment Options

Treatment focuses on managing rheumatoid arthritis and its complications. Disease-modifying antirheumatic drugs (DMARDs) are used to control joint inflammation, while granulocyte colony-stimulating factors may address neutropenia. Infections are treated promptly, and splenomegaly may require monitoring or intervention if symptomatic. Knee-specific treatments, such as physical therapy or joint injections, may be used to manage pain and preserve function.

Prognosis and Follow-Up

Prognosis depends on the severity of rheumatoid arthritis and associated complications. Early diagnosis and aggressive management of rheumatoid arthritis can improve outcomes, though neutropenia and infections remain significant risks. Regular follow-up is essential to monitor disease activity, neutrophil counts, and splenic size, with adjustments to treatment as needed.

Complications

• Increased risk of serious infections due to neutropenia
• Progressive joint damage in the knee and other affected joints
• Splenic rupture (rare)
• Anemia or thrombocytopenia (possible)
• Reduced quality of life from chronic pain and fatigue

Lifestyle & Prevention

• Maintain regular rheumatoid arthritis management to reduce disease activity
• Practice good hygiene to minimize infection risk
• Engage in low-impact exercises to preserve knee function
• Follow a balanced diet to support overall health
• Avoid smoking, which may worsen rheumatoid arthritis

When to Seek Professional Help

Seek medical attention if you experience:

• Sudden or worsening knee pain, swelling, or stiffness
• Signs of infection (e.g., fever, chills)
• Unexplained fatigue or weight loss
• Abdominal pain or fullness (possible splenomegaly)
• Recurrent or severe infections

Tips for Medical Coders

Document the presence of Felty's syndrome with knee involvement, including confirmation of rheumatoid arthritis, splenomegaly, and neutropenia. Ensure the knee is specified as the affected site. Include details on disease severity, treatment, and complications to support accurate coding. Note that this code is specific to knee involvement; do not use it for other joint sites.